Logo

Luminex Sees Revenues Slide, Losses Mount in Q2

Jul 26, 2002

NEW YORK, July 26-Revenues dwindled and losses mounted for Luminex in the second quarter of 2002, the company reported yesterday.

 

Revenues for the quarter ended June 30, 2002 were $3.2 million, down from $4.7 million in the second quarter of the previous year.

 

Losses increased to $6.1 million for the quarter ($0.21 per share) from $4.4 million or $0.15 per share in the equivalent quarter last year.

 

The company held $41 million in cash and short-term investments at the end of June, down from $51 million at the end of the 2001 calendar year.

 

Luminex chair and CEO Mark Chandler said in a statement that the company's revenues increased from the first quarter of the year, and pointed to a steep hike in royalties.

 

For more information, see the press release.

Breaking News
The Scan

Latent HIV Found in White Blood Cells of Individuals on Long-Term Treatments

Researchers in Nature Microbiology find HIV genetic material in monocyte white blood cells and in macrophages that differentiated from them in individuals on HIV-suppressive treatment.

Seagull Microbiome Altered by Microplastic Exposure

The overall diversity and the composition at gut microbiome sites appear to coincide with microplastic exposure and ingestion in two wild bird species, according to a new Nature Ecology and Evolution study.

Study Traces Bladder Cancer Risk Contributors in Organ Transplant Recipients

In eLife, genome and transcriptome sequencing reveal mutation signatures, recurrent somatic mutations, and risky virus sequences in bladder cancers occurring in transplant recipients.

Genes Linked to White-Tailed Jackrabbits' Winter Coat Color Change

Climate change, the researchers noted in Science, may lead to camouflage mismatch and increase predation of white-tailed jackrabbits.